RNA Formulation Solutions

  1. in vivo-jetRNA®+ 9/14/2022

    Efficient: 100% mRNA encapsulation leading to comparable LNP delivery results
    in vivo-jetRNA®+ is the reagent of choice to deliver mRNA to various organs. This is attributable to its intrinsic properties: in vivo-jetRNA®+ protects its payload against ubiquitous endonucleases, prevent non-specific interactions with proteins and promote efficient cell entry.

  2. pDNA Lipid Nanoparticle Formulation And Screening Using Nova IJM 1/24/2024

    Explore a platform designed to evaluate the effects of formulation and process parameters on the characteristics of DNA+LNP nanoparticles.

  3. in vivo mRNA Delivery Using Liposome-Based Reagent 12/12/2022

    in vivo-jetRNA®+ is a ready-to-use reagent that does not require formulation equipment that leads to 100% mRNA encapsulation leading to efficient mRNA delivery.

  4. Customized Skid For Large Production Scale: IJM NanoProducer 12/9/2024

    The Impingement Jets Mixing (IJM) Large Production Scale Units are designed for high-flow production of nanoparticles (LNP, micro-emulsions, etc) and can be configured with up to eight parallel mixing units depending on customer requirements.

  5. GenVoy-ILM™: Power To Explore 4/14/2022

    GenVoy-ILM is a pre-optimized lipid mixture designed to encapsulate RNA – mRNA, gRNA, siRNA, miRNA, tRNA – in LNP.

  6. Non-Viral Gene Delivery (NVGD) Using Polymeric-Nano Particles

    Examine a NVGD platform that tackles the primary obstacle hindering gene editing therapies: efficient delivery. Utilizing engineered nanoparticles, the platform overcomes limitations associated with payload size.

  7. DasherGRP mRNA: Optimized Fluorescent Protein 5/6/2026

    Fluorescent mRNA reporters enable rapid visual confirmation of delivery and expression in mammalian cells, with bright signal, transient expression, and quantitative readouts.

  8. Automated, Single-Use System For Clinical And Commercial LNP Production 7/21/2023

    The NanoAssemblr® commercial formulation system is an automated, single-use system for the clinical and commercial production of lipid nanoparticles (LNPs) under cGMP conditions. Designed for efficient changeover and robust manufacturing processes, the system enables operational flexibility and standardized manufacturing of genomic medicines.

  9. Single-Use System For Clinical And Commercial Production Of LNPs 7/21/2023

    Learn about a scalable, single-use platform with built-in automation and regulatory compliance that enables standardized manufacturing workflows for mRNA-LNP drug product production.

  10. Simplify The Encapsulation Process Of Nucleic Acid Payloads With FDmiX Technology 10/9/2026

    Enable a reliable, swift scale-up to cGMP manufacturing for mRNA encapsulation with the high-end FDmiX technology. Discover how to master challenges, streamline production, and enable faster, more predictable development of nucleic acid delivery systems.